Vr Adviser, LLC 89bio, Inc. Transaction History

Vr Adviser, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$24.34 - $38.82 $7.09 Million - $11.3 Million	-291,140 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$19.93 - $31.2 $13.2 Million - $20.6 Million	-661,060 Reduced 69.42%	291,140 $5.8 Million
Q1 2020 May 15, 2020	BUY	$16.4 - $41.77 $15.6 Million - $39.8 Million	952,200 New	952,200 $24 Million

165

108M

73.6K

1.19M

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $532M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.